HEALTH● LOWAug 26 · Aug 26, 2026, 11:55 AM
Summit rises as lead drug from Akeso outperforms Astra’s Imfinzi in late-stage trial
Seeking Alpha Tech
A drug called Summit, developed by Akeso, has reportedly outperformed Astra's Imfinzi in a late-stage trial. This indicates a significant development in pharmaceutical competition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoJapan goes on student suicide watch as school term startsSouth China Morning PostHEALTH1h agoToo Young To Be Sick Like Thisktep.org · United StatesHEALTH1h ago164 , 000 Reasons for Hope : New I Am Hope Boss Nick Baylis Takes Up Fight for Rangatahi Mental Healthwaateanews.com · New ZealandHEALTH1h ago25th anniversary of International Overdose Awareness Day marked in Nanaimo CHLY 101 . 7FM : Listener Supported in Nanaimo BC . chly.ca · Canada